iShares Biotechnology ETF Rating $130.02 +0.47 (+0.36%) Closing price 07/3/2025 03:57 PM EasternExtended Trading$130.08 +0.06 (+0.05%) As of 07/3/2025 04:12 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrendsBuy This Stock iShares Biotechnology ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBB Aggregate RatingModerate Buy 2.67Holdings in IBB have an aggregate rating of Moderate Buy based on 792 analyst ratings issued in the past year covering 50 companies (83.1% of the portfolio).IBB Aggregate Price Target$130.02High Prediction$130.02Average Prediction$130.02Low Prediction$130.02Holdings in IBB have an aggregate price target of $130.02 and a range of $130.02 to $130.02 covering 50 companies (83.1% of the portfolio).IBB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy14 Buy rating(s)Moderate Buy23 Moderate Buy rating(s)Hold13 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 IBB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.72%GILDGilead Sciences$111.28-0.2%4.8448 of 5 stars2.78$110.55 -0.7%27Positive NewsInsider Trade7.67%VRTXVertex Pharmaceuticals$454.64-0.5%4.7219 of 5 stars2.54$511.62 12.5%28Positive News7.39%AMGNAmgen$298.25+0.5%4.5254 of 5 stars2.35$307.82 3.2%236.37%REGNRegeneron Pharmaceuticals$545.00-0.5%4.9241 of 5 stars2.80$813.57 49.3%254.73%ALNYAlnylam Pharmaceuticals$331.94+0.7%4.3126 of 5 stars2.79$340.00 2.4%24Positive News3.17%IQVIQVIA$164.24-0.2%4.9158 of 5 stars2.75$226.32 37.8%242.88%MTDMettler-Toledo International$1,209.08+0.3%4.2887 of 5 stars2.42$1,300.36 7.5%12Positive News2.55%NTRANatera$161.500.0%2.1769 of 5 stars3.00$184.63 14.3%15Positive NewsInsider Trade2.53%ARGXargenex$543.32-0.3%4.3225 of 5 stars3.05$728.06 34.0%21Analyst Forecast2.46%WATWaters$350.22-0.5%4.499 of 5 stars2.61$388.00 10.8%182.17%BIIBBiogen$132.63-0.4%4.9345 of 5 stars2.38$188.48 42.1%322.08%INSMInsmed$98.50+0.3%4.1596 of 5 stars3.00$106.80 8.4%17Positive News1.88%BNTXBioNTech$109.65+1.3%2.3775 of 5 stars2.83$137.86 25.7%181.71%ILMNIllumina$100.44+0.1%4.909 of 5 stars2.47$127.39 26.8%19Positive News1.58%ONCBeOne Medicines$245.49+0.5%3.4386 of 5 stars3.00$320.67 30.6%61.53%INCYIncyte$68.46+0.4%4.3495 of 5 stars2.22$74.53 8.9%181.47%UTHRUnited Therapeutics$294.57-0.2%4.9955 of 5 stars2.69$386.15 31.1%13Positive News1.41%NBIXNeurocrine Biosciences$128.04-1.1%4.9201 of 5 stars2.86$162.00 26.5%22Positive News1.35%EXELExelixis$45.91+3.6%4.7451 of 5 stars2.52$43.56 -5.1%21Trending NewsAnalyst RevisionHigh Trading Volume1.22%BMRNBioMarin Pharmaceutical$57.25+0.1%4.9442 of 5 stars2.75$93.61 63.5%24Analyst Forecast1.09%MRNAModerna$30.47+0.6%4.3867 of 5 stars2.04$46.61 53.0%23Options Volume0.98%GMABGenmab A/S$20.41-0.1%3.5889 of 5 stars2.67$37.60 84.2%120.94%BPMCBlueprint Medicines$128.27+0.1%1.7373 of 5 stars2.27$128.06 -0.2%220.94%TECHBio-Techne$53.14-0.1%4.9729 of 5 stars2.45$72.00 35.5%11Positive News0.86%CRLCharles River Laboratories International$157.12-0.2%4.0563 of 5 stars2.19$171.85 9.4%160.85%MEDPMedpace$321.50-1.4%4.4589 of 5 stars2.21$344.82 7.3%140.85%BBIOBridgeBio Pharma$43.71+2.0%4.7031 of 5 stars2.93$58.85 34.6%14Insider TradeAnalyst Revision0.77%RGENRepligen$127.36+0.3%4.813 of 5 stars2.69$172.83 35.7%130.77%ASNDAscendis Pharma A/S$174.07+0.6%3.6726 of 5 stars3.00$220.67 26.8%15Analyst Forecast0.75%HALOHalozyme Therapeutics$54.05+0.4%4.852 of 5 stars2.17$61.90 14.5%120.73%IONSIonis Pharmaceuticals$42.98-1.4%4.6688 of 5 stars2.78$58.25 35.5%18Analyst Upgrade0.72%TEMTempus AI$60.65+2.5%2.2943 of 5 stars2.54$63.67 5.0%13Trending News0.71%MDGLMadrigal Pharmaceuticals$298.49-0.6%4.1045 of 5 stars2.89$420.63 40.9%90.70%RVMDRevolution Medicines$37.00-0.5%4.5843 of 5 stars3.00$67.58 82.7%12Analyst Revision0.56%ROIVRoivant Sciences$10.85-1.1%1.5673 of 5 stars3.00$17.50 61.4%40.55%ALKSAlkermes$28.75-0.9%4.9362 of 5 stars2.83$40.00 39.1%12Positive NewsAnalyst Revision0.53%VRNAVerona Pharma PLC American Depositary Share$91.18+1.2%2.6307 of 5 stars3.00$107.36 17.7%12Positive NewsAnalyst Forecast0.51%BRKRBruker$42.42-0.1%4.8032 of 5 stars2.40$52.89 24.7%10Positive News0.49%AXSMAxsome Therapeutics$105.36+1.4%4.7015 of 5 stars3.06$172.33 63.6%16Trending NewsAnalyst ForecastAnalyst Revision0.49%ADMAADMA Biologics$18.30+0.9%4.2153 of 5 stars3.33$27.67 51.2%30.48%PCVXVaxcyte$33.24-0.1%1.8251 of 5 stars3.10$136.50 310.7%10News Coverage0.47%AKROAkero Therapeutics$52.01+0.3%3.5687 of 5 stars3.00$82.50 58.6%6Insider Trade0.47%LEGNLegend Biotech$35.35-1.6%3.1374 of 5 stars2.91$72.60 105.4%11Analyst Forecast0.46%CRSPCRISPR Therapeutics$52.16+0.9%3.0381 of 5 stars2.53$71.75 37.6%170.45%PTCTPTC Therapeutics$48.77-0.8%4.3177 of 5 stars2.67$65.00 33.3%15Analyst Revision0.45%CYTKCytokinetics$33.90-1.3%3.9521 of 5 stars2.93$70.92 109.2%150.43%RYTMRhythm Pharmaceuticals$65.78-1.7%3.8185 of 5 stars3.00$77.31 17.5%13News Coverage0.43%ACADACADIA Pharmaceuticals$20.95-1.4%4.6936 of 5 stars2.71$27.88 33.1%170.42%NUVLNuvalent$80.37-0.2%3.7369 of 5 stars3.17$119.60 48.8%12Insider Trade0.41%SWTXSpringWorks Therapeutics$46.991.5377 of 5 stars2.13$52.57 11.9%8 This page (NASDAQ:IBB) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
